ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstract Number: 701

How Important Is Physical Activity for Patients with Systemic Lupus Erythematodes? -Results of Lula-Study

Isabelle Kloubert1, Gamal Chehab1, Jutta Richter2, Rebecca Fischer-Betz3, Ralph Brinks2 and Matthias Schneider1, 1Department of Rheumatology, Heinrich-Heine-University Duesseldorf, Duesseldorf, Germany, 2Rheumatology, Heinrich-Heine-University, Düsseldorf, Germany, 3Department of Rheumatology, University of Düsseldorf, Düsseldorf, Germany

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Disease Activity, physical activity, Quality of life and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Save to PDF
Session Information

Session Title: Systemic Lupus Erythematosus - Clinical Aspects and Treatment: Treatment and Management Studies

Session Type: Abstract Submissions (ACR)

Background/Purpose

Physical activity (PA) plays a decisive role in primary and secondary prevention in various domains of medicine. Our examination aimed to determine association PA and on outcomes in systemic lupus erythematodes (SLE).

Methods

The LuLa-Study is a prospective long-term study since 2001, which systematically collects patients’ reported outcomes among members of the German SLE Self-Help Organization. In 2006 and 2009 we analysed data of 750 patients (94.4% female, age 52.3±12.9 years (mean±SD), duration of disease 15.9 years in 2009) with regard to their PA applying the „Freiburger Questionnaire on physical activity“. We calculated the Metabolic Equivalent of Task (MET) for every patient. In the univariate analysis we compared 422 patients with low/intermediate PA (<30 MET, n=259) to those with high/very high activity (>30 MET, n=163) in both years. Furthermore, we examined the association of PA to disease activity, HRQoL (SF-12) and clinical symptoms in a multivariate regression analysis with age, sex, BMI and number of comorbidities. 

Results

The medium MET of the group with low/intermediate PA was 13.4±7.6 respectively, 73.9±31.5 with high/very high PA. A high PA in 2006 and 2009 was associated with less cephalgia (p<0.006) and muscle weakness (p<0.009) and with lower disease activity in 2009 (determined with SLE Activity Questionnaire (SLAQ) and VAS; p<0.001). No statistically significant relation between PA and myalgia or arthralgia could be found. Patients with high MET in 2006 and 2009 showed a better HRQoL (Physical Component Summary (p<0.001) and Mental Component Summary (p<0.014) determined with SF 12) in 2009. Both groups of activity improved their emotional HRQoL between 2006 and 2009, whereas the physical HRQoL stagnated in both groups. A higher PA in 2006 and 2009 was connected to a lower damage (determined by System Lupus International Collaborating Clinics/ACR Damage Index for SLE (SLICC-) Score; p<0.012) as well as to an improved fatigue (Vanderbilt Fatigue Score (VFS); p<0.001) and a different cognition of pain (FSS-Score; p<0.001) in 2009. The multivariate analysis included all 750 patients (medium MET in 2006 28.5±26.1, in 2009 34.5±37.7) and affirmed the influence of higher MET to the above outlined scores. It could be shown, that a higher PA of 10 MET is related to a decreasing SLAQ (-0.43 points) three years later (p<0.001). This effect remained after adjusting for the covariates. The same activity of 10 MET in 2009 is only associated with a decreasing SLAQ (-0.30 points) (p<0.001). A similar observation could be depicted for emotional and physical HRQoL. 

Conclusion

PA of SLE patients does have an impact on clinical manifestations and is related to a higher HRQoL. As increased PA has an impact on HRQoL and SLAQ three years later, a recommendation of more PA seems reasonable.


Disclosure:

I. Kloubert,

GlaxoSmithKline ,

9,

UCB,

9;

G. Chehab,

GlaxoSmithKline,

9,

UCB,

9;

J. Richter,

GlaxoSmithKline,

9,

UCB,

9;

R. Fischer-Betz,

GlaxoSmithKline,

9,

UCB,

9;

R. Brinks,

GlaxoSmithKline,

9,

UCB,

9;

M. Schneider,

GlaxoSmithKline,

9,

UCB,

9.

  • Tweet
  • Email
  • Print
Save to PDF

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/how-important-is-physical-activity-for-patients-with-systemic-lupus-erythematodes-results-of-lula-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.